Susquehanna International Group, LLP Karuna Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $9.08 Million - $17.9 Million	56,400 Added 58.39%	153,000 $48.4 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $1.02 Million - $1.35 Million	-6,200 Reduced 6.03%	96,600 $16.3 Million
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $1.59 Million - $2.16 Million	-9,000 Reduced 8.05%	102,800 $22.3 Million
Q1 2023 May 16, 2023	BUY	$161.33 - $204.36 $11.7 Million - $14.8 Million	72,300 Added 183.04%	111,800 $20.3 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $3.03 Million - $3.74 Million	-15,800 Reduced 28.57%	39,500 $7.76 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $631,329 - $1.41 Million	-5,100 Reduced 8.44%	55,300 $12.4 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.